The effect of different antidepressant drugs on oxidative stress after lipopolysaccharide administration in mice

EXCLI Journal

Volumn 10, Issue , 2011, Pages 290-302

  Abdel Salam, Omar M E ^a   Youssef Morsy, Safaa M ^a   Sleem, Amany A ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Antidepressant drugs; Brain; Lipopolysaccharide; Liver; Mice; Oxidative stress

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN PROTEIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; NITRIC OXIDE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; LIPID ANALYSIS; LIPID PEROXIDATION; LIVER LEVEL; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BACTERIA (MICROORGANISMS); MUS;

EID: 84855803996     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Abdel Salam OME, Sleem AA, Shaffie NM. Effect of the selective serotonin reuptake inhibitor fluoxetine on carbon tetrachloride induced hepatic damage in rats. J Pharmacol Toxicol 2006;1:395-406.
2. Abdel Salam OME, Sleem AA, Shafee N. Effect of trazodone and nefazodone on hepatic injury induced by carbon tetrachloride. Drug Discov Ther 2010a;4:285-97.
3. Abdel Salam OME, Sleem AA, Shafee N. The effect of serotonin reuptake inhibitors on hepatic injury induced by crbon tetrachloride. J Comp Pathol 2010b http://dx.doi.org/10.1007/s00580-010-1067-5
4. Abdel-Salam OME, Sleem AA, Shaffie N. Hypericum perforatum protects against he-patic injury induced by carbon tetrachloride Comp Clin Pathol 2011 http://dx.doi.org/10.1007/s00580-011-1252-1
5. Bianchi M, Rossoni G, Sacerdote P, Panerai AE, Berti F. Effects of chlomipramine and fluoxetine on subcutaneous carrageenin-induced inflammation in the rat. Inflamm Res 1995;44:466-9.
6. Brown GC. Nitric oxide and neuronal death. Nitric Oxide 2010;23:153-65.
7. Bymaster FP, Zhang W, Carter PA, Shaw J, Chernet E, Phebus L et al. Fluoxetine, but not other selective serotonin uptake inhibi-tors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berl) 2002;160: 353-61.
8. Cai W, Khaoustov VI, Xie Q, Pan T, Le W, Yoffe B. Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression. J Hepatol 2005;42:880-7.
9. Chen SJ, Kao CL, Chang YL, Yen CJ, Shui JW, Chien CS et al. Antidepressant admini-stration modulates neural stem cell survival and serotoninergic differentiation through bcl-2. Curr Neurovasc Res. 2007;4:19-29.
10. Chung ES, Chung YC, Bok E, Baik HH, Park ES, Park JY et al. Fluoxetine prevents LPS-induced degeneration of nigral dopa-minergic neurons by inhibiting microglia-mediated oxidative stress. Brain Res 2010a; 1363:143-50.
11. Chung YC, Kim SR, Jin BK. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease. J Immunol 2010b;185:1230-7.
12. Cozzi A, Zignego AL, Carpendo R, Bi-agiotti T, Aldinucci A, Monti M et al. Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients. J Viral Hepat 2006;13:402-8.
13. Czapski GA, Cakala M, Chalimoniuk M, Gajkowska B, Strosznajder JB. Role of nitric oxide in the brain during lipopolysac-charide-evoked systemic inflammation. J Neurosci Res 2007;85:1694-703.
14. Dawson VL, Dawson TM. Nitric oxide neurotoxicity. J Chem Neuroanat 1996;10: 179-90.
15. Dean OM, van den Buuse M, Bush AI, Co-polov DL, Ng F, Dodd S et al. A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice. Curr Med Chem 2009;16:2965-76.
16. Drzyzga LR, Marcinowska A, Obuchowicz E. Antiapoptotic and neurotrophic effects of antidepressants: A review of clinical and experimental studies. Brain Res Bull 2009; 79:248-57.
17. Ellman GL. Tissue sulfhydryl groups. Arch Biochem 1959;82:70-7.
18. Felton TM, Kang TB, Hjorth S, Auerbach SB. Effects of selective serotonin and sero-tonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Naunyn-Schmiedebergs Arch Pharmacol 2003;367:297-305.
19. Fuller RW. Uptake inhibitors increase ex-tracellular serotonin concentration meas-ured by brain microdialysis. Life Sci 1994; 55:163-7.
20. Gawryluk JW, Wang JF, Andreazza AC, Shao L, Young LT. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsy-chopharmacol 2011;14:123-30.
21. Gibbons SS. Antidepressants. In: Edmunds MW, Mayhew MS (eds.): Pharmacology for the primary care provider St. Louis, MI: Mosby, 2000 (pp 602-20).
22. Gleason OC, Yates WR, Isbell MD, Philip-sen MA. An open-label trial of citalopram for major depression in patients with hepatitis C. J Clin Psychiatry 2002;63:194-8.
23. Goodnick PJ, Goldstein BJ. Selective sero-tonin reuptake inhibitors in affective disor-ders. I. Basic pharmacology. J Psycho Pharmacol 1998;12(3 Suppl B):S5-20.
24. Gutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995;41:1819-28.
25. Ha E, Jung KH, Choe BK, Bae JH, Shin DH, Yim SV et al. Fluoxetine increases the nitric oxide production via nuclear factor kappa B-mediated pathway in BV2 murine microglial cells. Neurosci Lett 2006;397: 185-9.
26. Harvey BH, Retief R, Korff A, Wegener G. Increased hippocampal nitric oxide synthase activity and stress responsiveness af-ter imipramine discontinuation: role of 5HT 2A/C-receptors. Metab Brain Dis 2006;21: 211-20.
27. Hashioka S, Klegeris A, Monji A, Kato T, Sawada M, McGeer PL et al. Antidepres-sants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp Neurol 2007;206:33-42.
28. Horikawa H, Kato TA, Mizoguchi Y, Monji A, Seki Y, Ohkuri T et al. Inhibitory effects of SSRIs on IFN-γ induced microglial activation through the regulation of intracellular calcium. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:1306-16.
29. Hwang J, Zheng LT, Ock J, Lee MG, Kim SH, Lee HW et al. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology 2008;55:826-34.
30. Ijaz S, Yang W, Winslet MC, Seifalian AM. The role of nitric oxide in the modula-tion of hepatic microcirculation and tissue oxygenation in an experimental model of hepatic steatosis. Microvasc Res 2005;70: 129-36.
31. Jacewicz M, Czapski GA, Katkowska I, Strosznajder RP. Systemic administration of lipopolysaccharide impairs glutathione redox state and object recognition in male mice. The effect of PARP-1 inhibitor. Folia Neuropathol 2009;47:321-8.
32. Jeong H-K, Jou I, Joe EH. Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra. Exp Mol Med 2010;42: 823-32.
33. Kitaichi Y, Inoue T, Nakagawa S, Boku S, Kakuta A, Izumi T et al. Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats. Eur J Pharmacol 2010;647:90-6.
34. Kolla N, Wei Z, Richardson JS, Li XM. Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide. Psychiatry Neurosci 2005;30: 196-201.
35. Kozak W, Kozak A. Selected contribution: Differential role of nitric oxide synthase isoforms in fever of different etiologies: studies using NOS gene-deficient mice. J Appl Physiol 2003;94:2534-44.
36. Krass M, Wegener G, Vasar E, Volke V. The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis. Behav Brain Res 2011;218:57-63.
37. Lang JP, Meyer N, Doffoel M. Benefits of a preventive psychiatric accompaniment in patients Hepatitis C Virus seropositive (HCV): prospective study concerning 39 patients (in French). Encephale 2003;29: 362-5.
38. Lang PA, Contaldo C, Georgiev P, El-Badry AM, Recher M, Kurrer M et al. Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med 2008;14:756-61.
39. Lee CH, Park JH, Yoo KY, Choi JH, Hwang IK, Ryu PD et al. Pre-and post-treatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxida-tive stress. Exp Neurol 2011;229:450-9.
40. Lesurtel M, Soll C, Graf R, Clavien PA. Role of serotonin in the hepato-gastro-intestinal tract: an old molecule for new perspectives. Cell Mol Life Sci 2008;65: 940-52.
41. Lhuillier F, Robert MO, Crova P, Goudable J, Arnal F, Cespuglio R et al. Nitric oxide and liver microcirculation during autoregulation and haemorrhagic shock in rabbit model. Br J Anaesth 2006;97:137-46.
42. Liu D, Wang Z, Liu S, Wang F, Zhao S, Hao A. Anti-inflammatory effects of fluoxetine in lipopolysaccharide (LPS)-stimulated microglial cells. Neuropharmacology 2011;61:592-9.
43. Lozeva-Thomas V. Serotonin brain circuits with a focus on hepatic encephalopathy. Metab Brain Dis 2004;19:413-20.
44. Maes M. The cytokine hypothesis of de-pression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in de-pression. Neuroendocrinol Lett 2008;29: 287-91.
45. Maurer-Spurej E, Pittendreigh C, Solomons K. The influence of selective serotonin re-uptake inhibitors on human platelet sero-tonin. Thromb Haemost 2004;91:119-28.
46. Mittal MK, Gupta TK, Lee FY, Sieber CC, Groszmann RJ. Nitric oxide modulates hepatic vascular tone in normal rat liver. Am J Physiol 1994;267:G416-22.
47. Moncada S, Bolaños JP. Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 2006;97:1676-89.
48. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109-42.
49. Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determination in plasma: A critical evaluation. Clin Chem 1995;41:892-6.
50. Murata R, Hamada N, Nakamura N, Koba-yashi A, Fukueda M, Taira A et al. Serotonin activity and liver dysfunction following hepatic ischemia and reperfusion. In Vivo 2003;17:567-72.
51. Muriel P. Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride. Biochem Pharmacol 1998; 56:773-9.
52. Noble F, Rubira E, Boulanouar M, Palmier B, Plotkine M, Warnet JM et al. Acute systemic inflammation induces central mitochondrial damage and mnesic deficit in adult Swiss mice. Neurosci Lett 2007;424: 106-10.
53. Nocito A, Georgiev P, Dahm F, Jochum W, Bader M, Graf R et al. Platelets and plate-let-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology 2007;45:369-76.
54. Paget GE, Barnes JM. Toxicity tests. In: Laurence DR, Bacharach AL (eds.): Evaluation of drug activities. Pharmacometrics. London: Academic Press, 1964 (p 161).
55. Pang Y, Campbell L, Zheng B, Fan L, Cai Z, Rhodes P. Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience 2010;166:464-75.
56. Peng CH, Chiou SH, Chen SJ, Chou YC, Ku HH, Cheng CK et al. Neuroprotection by imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway. Eur Neu-ropsychopharmacol 2008;18:128-40.
57. Pozzi L, Invernizzi R, Garavaglia C, Samanin R. Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram. J Neurochem 1999;73:1051-7.
58. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007;55:453-62.
59. Reilly FD, Cilento EV, McCuskey RS. Hepatic microvascular regulatory mechanisms. V. Effects of lodoxamide tromethamine or phentolamine-HCl on vascular responses elicited by serotonin. Microcirc Endothe-lium Lymphatics 1984;1:671-89.
60. Réus GZ, Stringari RB, de Souza B, Petronilho F, Dal-Pizzol F, Hallak JE et al. Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus. Oxid Med Cell Longev 2010;3: 325-31.
61. Ruiz-Larrea MB, Leal AM, Liza M, Lacort M, de Groot H. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 1994;59:383-8.
62. Sánchez C, Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 1999; 19:467-89.
63. Schäfer M, Schmidt F, Amann B, Schlösser S, Loeschke K, Grunze H. Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizo-affective psychosis. Neuropsychobiology 2000;42(Suppl 1):43-5.
64. Schulz JB, Lindenau J, Seyfried J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 2000;267:4904-11.
65. Serebruany VL, Gurbel PA, O'Connor CM. Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin re-uptake inhibitors. Pharmacol Res 2001;43: 453-62.
66. Spencer SJ, Mouihate A, Pittman QJ. Peripheral inflammation exacerbates damage after global ischemia independently of temperature and acute brain inflammation. Stroke 2007;38:1570-7.
67. Tuncyurek P, Yenisey C Doger FK, Soyder A, Bicakci T, Cevikel MH. Nitric oxide as an independent regulatory factor in regenerating rat liver. Acta Chir Belg 2006;106: 581-7.
68. Vila JM, Medina P, Segarra G, Lluch P, Pallardo F, Flor B et al. Relaxant effects of antidepressants on human isolated mesenteric arteries. Br J Clin Pharmacol 1999;48; 223-9.
69. Wang W, Ballatori N. Endogenous glutathione conjugates: occurrence and bio-logical functions. Pharmacol Rev 1998;50: 335-56.
70. Wood SJ, Yücel M, Pantelis C, Berk M. Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress. Ann Acad Med Singapore 2009;38:396-401.
71. Wu G, Fang Y, Yang S, Lupton JR, Turner ND: Glutathione metabolism and its implications for health. J Nutr 2004;134:489-92.